Mycobutin (Rifabutin)

Rifabutin, the active ingredient in Mycobutin, is a rifamycin antibiotic presented as an unknown strength/oral tablet for oral use. It treats Mycobacterium avium complex infections and tuberculosis in adult patients. GNH USA supplies Mycobutin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Rifabutin is a rifamycin antibiotic used in the management of mycobacterial infections. - Mycobacterium avium complex (MAC) infection: prophylaxis and treatment in immunocompromised adults. - Tuberculosis (TB): component of combination therapy for active disease, including drug‑resistant strains. - HIV‑associated MAC disease: prevention in patients with low CD4 counts.

Rifabutin may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild gastrointestinal upset. - Diarrhea: loose stools, often transient. - Rash: skin redness or itching. - Fever: low‑grade temperature elevation. - Abdominal pain: discomfort in the stomach area. - Elevated liver enzymes: mild hepatic enzyme rise.

Serious or Rare Side Effects: - Hepatotoxicity: significant liver injury requiring monitoring. - Neutropenia: marked reduction in white blood cells. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Visual disturbances: blurred vision or color changes. - Hypersensitivity: anaphylactic reactions. - Peripheral neuropathy: tingling or numbness in extremities.

Before initiating Rifabutin therapy, consider the following safety measures. - Liver function: assess baseline hepatic enzymes and monitor periodically. - Blood counts: check complete blood count to detect neutropenia or anemia. - Drug interactions: review concomitant medications for CYP3A inducers or inhibitors. - Pregnancy and lactation: evaluate risk‑benefit ratio; use only if clearly needed. - Renal impairment: adjust monitoring in patients with reduced kidney function. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture.

Rifabutin interacts with several drug classes; awareness helps avoid reduced efficacy or toxicity.

Major Interactions (Avoid): - Strong CYP3A inducers (e.g., rifampicin, carbamazepine): markedly lower Rifabutin levels. - Antiretrovirals (e.g., protease inhibitors boosted with ritonavir): increase Rifabutin exposure, risk of toxicity.

Moderate Interactions (Monitor Closely): - Macrolide antibiotics (e.g., azithromycin, clarithromycin): may raise Rifabutin concentrations. - Warfarin: potential enhancement of anticoagulant effect. - Fluoroquinolones: additive risk of tendon disorders. - Oral contraceptives: reduced hormonal efficacy, consider backup contraception. - Antifungals (e.g., fluconazole): may increase Rifabutin levels modestly.